2KLN

Solution Structure of STAS domain of RV1739c from M. tuberculosis

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
2	2D 1H-13C HSQC	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
3	2D 1H-1H TOCSY	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
4	2D 1H-1H NOESY	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
5	3D HNCA	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
6	3D HN(CO)CA	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
7	3D HNCACB	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
8	3D HN(COCA)CB	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
9	3D HNCO	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
10	3D HBHA(CO)NH	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
11	3D H(CCO)NH	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
12	3D C(CO)NH	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
13	3D HCCH-TOCSY	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
14	3D HNHA	0.6 to 0.8 mM [U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
15	3D 1H-15N NOESY	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
16	3D 1H-13C NOESY	0.6 to 0.8 mM [U-100% 13C; U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
17	2D 1H-15N HSQC	0.6 to 0.8 mM [U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
18	3D 1H-15N NOESY	0.6 to 0.8 mM [U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
19	3D HNHA	0.6 to 0.8 mM [U-100% 15N], STAS domain of Rv1739C, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
20	2D 1H-1H TOCSY	0.6 to 0.8 mM STAS domain of Rv1739C-13, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298
21	2D 1H-1H NOESY	0.6 to 0.8 mM STAS domain of Rv1739C-13, 50 mM sodium phosphate, 275 mM sodium chloride, 2 mM [U-2H] DTT-d10, 0.25 mM DSS, 0.05% w/v sodium azide	92% H2O/8% D2O	275	7.2	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics, DGSA-distance geometry simulated annealing		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	400
Conformers Submitted Total Number	25
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	NMRPipe	2007.030.16.06	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	processing	NMRPipe	2007.030.16.06	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	peak picking	NMRPipe	2007.030.16.06	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	NMRDraw	3.0 Rev 2007.068.09.07	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	peak picking	NMRDraw	3.0 Rev 2007.068.09.07	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	data analysis	ANSIG	3.3	Kraulis
7	chemical shift assignment	ANSIG	3.3	Kraulis
8	geometry optimization	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
9	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
10	refinement	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read